ARTICLE | Distillery Therapeutics
Therapeutics: Nuclear receptor subfamily 4 group A member 1 (NR4A1; NURR77); tyrosine hydroxylase (TYH)
January 7, 2016 8:00 AM UTC
In vitro and mouse studies suggest promoting NR4A1 expression or inhibiting TYH could help treat MS. In monocytes from MS patients, TYH levels were higher than in monocytes from healthy controls. In m...